Joinn Laboratories(China)Co Asset Resilience Ratio

Latest as of March 2026: 15.05%

Joinn Laboratories(China)Co asset resilience ratio. Joinn Laboratories(China)Co (603127) has an Asset Resilience Ratio of 15.05% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Joinn Laboratories(China)Co defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.

Liquid Assets

CN¥1.51 Billion
≈ $221.09 Million USD Cash + Short-term Investments

Total Assets

CN¥10.04 Billion
≈ $1.47 Billion USD All company assets

Resilience Assessment

Good
Financial Resilience Level

Asset Resilience Ratio of Joinn Laboratories(China)Co (2017–2025)

Asset resilience ratio of Joinn Laboratories(China)Co from 2017 to 2025. This chart shows how Joinn Laboratories(China)Co's Asset Resilience Ratio has changed over time. Read 603127 total debt and obligations for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Joinn Laboratories(China)Co's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Joinn Laboratories(China)Co (603127) total assets.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents CN¥0.00 0%
Short-term Investments CN¥1.51 Billion 15.05%
Total Liquid Assets CN¥1.51 Billion 15.05%

Asset Resilience Insights

  • Good Liquidity Position: Joinn Laboratories(China)Co maintains a healthy 15.05% of assets in liquid form.
  • This level provides good financial flexibility while maintaining productive asset deployment.
  • The company has significant short-term investments, indicating active treasury management.

Joinn Laboratories(China)Co Industry Peers by Asset Resilience Ratio

Compare Joinn Laboratories(China)Co's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Zhejiang DiAn Diagnostics Co
SHE:300244
Diagnostics & Research 3.61%
Shanghai Runda Med Tech Co
SHG:603108
Diagnostics & Research 0.42%
Cowealth Medical China Co.Ltd.
SHG:603122
Diagnostics & Research 2.25%
Lumibird SA
PA:LBIRD
Diagnostics & Research 22.85%
Monash Ivf Group Ltd
AU:MVF
Diagnostics & Research 1.60%
Leveljump Healthcare Corp
V:JUMP
Diagnostics & Research 32.45%
Avricore Health Inc
V:AVCR
Diagnostics & Research 1.71%
Inoviq Ltd
AU:IIQ
Diagnostics & Research 56.29%

Joinn Laboratories(China)Co Asset Resilience Ratio by Year (2017–2025)

Joinn Laboratories(China)Co asset resilience ratio by year from 2017 to 2025. The table below shows the annual Asset Resilience Ratio data for Joinn Laboratories(China)Co.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-12-31 17.75% CN¥1.72 Billion
≈ $251.44 Million
CN¥9.68 Billion
≈ $1.42 Billion
+2.89pp
2024-12-31 14.86% CN¥1.40 Billion
≈ $204.30 Million
CN¥9.40 Billion
≈ $1.37 Billion
+11.14pp
2023-12-31 3.72% CN¥373.35 Million
≈ $54.63 Million
CN¥10.03 Billion
≈ $1.47 Billion
-0.22pp
2022-12-31 3.94% CN¥408.47 Million
≈ $59.77 Million
CN¥10.36 Billion
≈ $1.52 Billion
-4.04pp
2021-12-31 7.98% CN¥680.98 Million
≈ $99.65 Million
CN¥8.54 Billion
≈ $1.25 Billion
-3.36pp
2020-12-31 11.33% CN¥238.90 Million
≈ $34.96 Million
CN¥2.11 Billion
≈ $308.44 Million
+2.12pp
2019-12-31 9.22% CN¥130.70 Million
≈ $19.13 Million
CN¥1.42 Billion
≈ $207.47 Million
+0.21pp
2018-12-31 9.01% CN¥102.85 Million
≈ $15.05 Million
CN¥1.14 Billion
≈ $167.02 Million
+8.96pp
2017-12-31 0.06% CN¥519.97K
≈ $76.09K
CN¥940.87 Million
≈ $137.68 Million
--
pp = percentage points

About Joinn Laboratories(China)Co

SHG:603127 China Diagnostics & Research
Market Cap
$4.11 Billion
CN¥28.08 Billion CNY
Market Cap Rank
#3941 Global
#543 in China
Share Price
CN¥44.55
Change (1 day)
-4.30%
52-Week Range
CN¥26.50 - CN¥53.90
All Time High
CN¥175.47
About

Joinn Laboratories(China)Co.,Ltd. provides preclinical and non-clinical services in the United States, the People's Republic of China, and internationally. It operates through three segments: Non-Clinical Studies Services; Clinical Trial and Related Services; and Sales of Research Models. The Non-Clinical Studies Services segment offers drug safety assessment, drug metabolism and pharmacokinetics… Read more